Coagulation abnormalities have also been reported in patients with COVID-19, including increased D-dimer levels, prolonged prothrombin times (PT), prolonged activated partial thromboplastin times (aPTT), and mild thrombocytopenia [43,44]. Here, F2 is linked to COVID-19.